Price to Sales (P/S)
since 2005
Calculation
Pfizer Inc., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenues1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | 2.66 | = | 27.55 | ÷ | 10.36 | 10.36 | = | 58,496 | ÷ | 5,646,778,425 | |
| Feb 23, 2023 | 2.37 | = | 42.30 | ÷ | 17.86 | 17.86 | = | 100,330 | ÷ | 5,619,074,621 | |
| Feb 24, 2022 | 3.18 | = | 45.96 | ÷ | 14.46 | 14.46 | = | 81,288 | ÷ | 5,623,346,471 | |
| Feb 25, 2021 | 4.50 | = | 33.82 | ÷ | 7.51 | 7.51 | = | 41,908 | ÷ | 5,577,629,491 | |
| Feb 27, 2020 | 3.66 | = | 34.10 | ÷ | 9.33 | 9.33 | = | 51,750 | ÷ | 5,547,639,005 | |
| Feb 28, 2019 | 4.49 | = | 43.35 | ÷ | 9.66 | 9.66 | = | 53,647 | ÷ | 5,551,804,790 | |
| Feb 22, 2018 | 4.05 | = | 35.74 | ÷ | 8.83 | 8.83 | = | 52,546 | ÷ | 5,952,864,751 | |
| Feb 23, 2017 | 3.84 | = | 34.06 | ÷ | 8.88 | 8.88 | = | 52,824 | ÷ | 5,951,872,174 | |
| Feb 29, 2016 | 3.76 | = | 29.67 | ÷ | 7.90 | 7.90 | = | 48,851 | ÷ | 6,184,139,991 | |
| Feb 27, 2015 | 4.24 | = | 34.32 | ÷ | 8.09 | 8.09 | = | 49,605 | ÷ | 6,128,855,392 | |
| Feb 28, 2014 | 3.97 | = | 32.11 | ÷ | 8.08 | 8.08 | = | 51,584 | ÷ | 6,382,925,343 | |
| Feb 28, 2013 | 3.34 | = | 27.37 | ÷ | 8.20 | 8.20 | = | 58,986 | ÷ | 7,189,061,853 | |
| Feb 28, 2012 | 2.37 | = | 21.22 | ÷ | 8.94 | 8.94 | = | 67,425 | ÷ | 7,538,520,276 | |
| Feb 28, 2011 | 2.27 | = | 19.24 | ÷ | 8.48 | 8.48 | = | 67,809 | ÷ | 7,995,220,402 | |
| Feb 26, 2010 | 2.83 | = | 17.55 | ÷ | 6.20 | 6.20 | = | 50,009 | ÷ | 8,070,372,772 | |
| Feb 27, 2009 | 1.72 | = | 12.31 | ÷ | 7.16 | 7.16 | = | 48,296 | ÷ | 6,745,269,668 | |
| Feb 29, 2008 | 3.11 | = | 22.28 | ÷ | 7.16 | 7.16 | = | 48,418 | ÷ | 6,760,988,882 | |
| Mar 1, 2007 | 3.67 | = | 25.04 | ÷ | 6.83 | 6.83 | = | 48,371 | ÷ | 7,086,916,026 | |
| Mar 1, 2006 | 3.77 | = | 26.26 | ÷ | 6.97 | 6.97 | = | 51,298 | ÷ | 7,357,943,810 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Pfizer Inc. Annual Report.
Comparison to Competitors
Pfizer Inc., P/S, long-term trends, comparison to competitors
| Pfizer Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | 2.66 | 5.72 | 5.78 | 2.19 | 7.76 | 20.77 | 3.40 | 4.43 | 5.43 | 7.84 | 4.99 |
| Feb 23, 2023 | 2.37 | 4.61 | 5.17 | 3.29 | 5.79 | 10.96 | 3.86 | 4.34 | 4.71 | 7.01 | 4.73 |
| Feb 24, 2022 | 3.18 | 4.53 | 5.10 | 3.16 | 6.37 | 8.01 | 2.85 | 4.66 | 3.96 | 4.20 | 5.39 |
| Feb 25, 2021 | 4.50 | 4.05 | 5.64 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 3.93 | 6.24 | 5.52 |
| Feb 27, 2020 | 3.66 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | 5.34 | 4.83 |
| Feb 28, 2019 | 4.49 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | 6.62 | 4.24 |
| Feb 22, 2018 | 4.05 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | 5.92 | 4.01 |
| Feb 23, 2017 | 3.84 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | 7.86 | 3.37 |
| Feb 29, 2016 | 3.76 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | 9.38 | 3.05 |
| Feb 27, 2015 | 4.24 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | 14.62 | 3.06 |
| Feb 28, 2014 | 3.97 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | 15.52 | 3.74 |
| Feb 28, 2013 | 3.34 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | 11.66 | 2.12 |
| Feb 28, 2012 | 2.37 | — | 3.52 | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.43 | 20.90 | 1.77 |
| Feb 28, 2011 | 2.27 | — | 3.32 | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.18 | 7.38 | 2.00 |
| Feb 26, 2010 | 2.83 | — | 3.88 | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 4.23 | 5.74 | 1.98 |
| Feb 27, 2009 | 1.72 | — | 3.44 | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 2.14 | 5.17 | 1.44 |
| Feb 29, 2008 | 3.11 | — | 3.46 | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 4.04 | 11.94 | 2.40 |
| Mar 1, 2007 | 3.67 | — | 5.41 | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 4.23 | 19.70 | 5.05 |
| Mar 1, 2006 | 3.77 | — | 7.24 | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.50 | 14.06 | 2.15 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Pfizer Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Pfizer Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 22, 2024 | 2.66 | 5.79 |
| Feb 23, 2023 | 2.37 | 4.50 |
| Feb 24, 2022 | 3.18 | 4.45 |
| Feb 25, 2021 | 4.50 | 4.85 |
| Feb 27, 2020 | 3.66 | 4.76 |
| Feb 28, 2019 | 4.49 | 4.44 |
| Feb 22, 2018 | 4.05 | 4.51 |
| Feb 23, 2017 | 3.84 | 4.24 |
| Feb 29, 2016 | 3.76 | 4.05 |
| Feb 27, 2015 | 4.24 | 4.46 |
| Feb 28, 2014 | 3.97 | 4.25 |
| Feb 28, 2013 | 3.34 | 3.24 |
| Feb 28, 2012 | 2.37 | 2.56 |
| Feb 28, 2011 | 2.27 | 2.41 |
| Feb 26, 2010 | 2.83 | 2.96 |
| Feb 27, 2009 | 1.72 | 2.20 |
| Feb 29, 2008 | 3.11 | 3.18 |
| Mar 1, 2007 | 3.67 | 3.87 |
| Mar 1, 2006 | 3.77 | 3.82 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Pfizer Inc., P/S, long-term trends, comparison to industry (health care)
| Pfizer Inc. | Health Care | |
|---|---|---|
| Feb 22, 2024 | 2.66 | 2.29 |
| Feb 23, 2023 | 2.37 | 33,555.66 |
| Feb 24, 2022 | 3.18 | 2.26 |
| Feb 25, 2021 | 4.50 | 2.20 |
| Feb 27, 2020 | 3.66 | 2.12 |
| Feb 28, 2019 | 4.49 | 2.32 |
| Feb 22, 2018 | 4.05 | 2.30 |
| Feb 23, 2017 | 3.84 | 2.12 |
| Feb 29, 2016 | 3.76 | 2.10 |
| Feb 27, 2015 | 4.24 | 2.38 |
| Feb 28, 2014 | 3.97 | 2.17 |
| Feb 28, 2013 | 3.34 | 1.73 |
| Feb 28, 2012 | 2.37 | 1.55 |
| Feb 28, 2011 | 2.27 | 1.46 |
| Feb 26, 2010 | 2.83 | 1.64 |
| Feb 27, 2009 | 1.72 | 1.36 |
| Feb 29, 2008 | 3.11 | 2.01 |
| Mar 1, 2007 | 3.67 | 2.43 |
| Mar 1, 2006 | 3.77 | 2.72 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).